Products
Are you looking for life science and diagnostic reagents? We offer one of the most extensive ranges in the Benelux. There are currently more than 8 million products in our webshop, which are manufactured by more than 130 suppliers. We hope to support your research with everything you need.
![Dystrophin (DMD) (Marker of Duchenne and Becker Muscular Dystrophy)(DMD/3241), CF640R conjugate, 0.1mg/mL [26628-22-8]](https://biotium.com/wp-content/uploads/2021/02/view_image-379.jpeg)
Product group Antibodies
ApplicationsImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
ReactivityHuman
TargetDMD
- SizePrice
![Dystrophin (DMD) (Marker of Duchenne and Becker Muscular Dystrophy)(DMD/3242), CF640R conjugate, 0.1mg/mL [26628-22-8]](https://biotium.com/wp-content/uploads/2021/02/view_image-380.jpeg)
Product group Antibodies
ApplicationsImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
ReactivityHuman
TargetDMD
- SizePrice
![Dystrophin (DMD) (Marker of Duchenne and Becker Muscular Dystrophy)(DMD/3243), CF640R conjugate, 0.1mg/mL [26628-22-8]](https://biotium.com/wp-content/uploads/2021/02/view_image-381.jpeg)
Product group Antibodies
ApplicationsImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
ReactivityHuman
TargetDMD
- SizePrice
![Dystrophin (DMD) (Marker of Duchenne and Becker Muscular Dystrophy)(DMD/3244), CF640R conjugate, 0.1mg/mL [26628-22-8]](https://biotium.com/wp-content/uploads/2021/02/view_image-382.jpeg)
Product group Antibodies
ApplicationsImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
ReactivityHuman
TargetDMD
- SizePrice
![Dystrophin (DMD) (Marker of Duchenne and Becker Muscular Dystrophy)(DMD/3245), CF640R conjugate, 0.1mg/mL [26628-22-8]](https://biotium.com/wp-content/uploads/2021/02/view_image-383.jpeg)
Product group Antibodies
ApplicationsImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
ReactivityHuman
TargetDMD
- SizePrice
![CD21 (Mature B-Cell & Follicular Dendritic Cell Marker)(CR2/3247), CF640R conjugate, 0.1mg/mL [26628-22-8]](https://biotium.com/wp-content/uploads/2021/02/view_image-359.jpeg)
Product group Antibodies
ApplicationsImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
ReactivityHuman
TargetCR2
- SizePrice
![CD1a / HTA1 (Mature Langerhans Cells Marker)(C1A/3249), CF640R conjugate, 0.1mg/mL [26628-22-8]](https://biotium.com/wp-content/uploads/2021/02/view_image-268.jpeg)
Product group Antibodies
CD1a / HTA1 (Mature Langerhans Cells Marker)(C1A/3249), CF640R conjugate, 0.1mg/mL [26628-22-8]BNC403249
ReactivityHuman
TargetCD1A
- SizePrice
![E-Cadherin (CDH1) / CD324 (Intercellular Junction Marker)(CDH1/3256), CF640R conjugate, 0.1mg/mL [26628-22-8]](https://biotium.com/wp-content/uploads/2021/02/view_image-333.jpeg)
Product group Antibodies
ApplicationsFlow Cytometry, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
ReactivityHuman
TargetCDH1
- SizePrice
![HER-2 / c-erbB-2 / neu / CD340(ERBB2/3257), CF640R conjugate, 0.1mg/mL [26628-22-8]](https://biotium.com/wp-content/uploads/2021/02/view_image-401.jpeg)
Product group Antibodies
ApplicationsFlow Cytometry, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
ReactivityHuman
TargetERBB2
- SizePrice
![ICOS-L / ICOS Ligand / B7RP-1 (Immuno-Oncology Target)(ICOSL/3260), CF640R conjugate, 0.1mg/mL [26628-22-8]](https://biotium.com/wp-content/uploads/2021/02/view_image-479.jpeg)
Product group Antibodies
ApplicationsImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
ReactivityHuman
TargetFem1b
- SizePrice
![Lymphocyte Activation Gene 3 (LAG-3) (Negative Checkpoint Regulator)(LAG3/3261), CF640R conjugate, 0.1mg/mL [26628-22-8]](https://biotium.com/wp-content/uploads/2021/02/view_image-538.jpeg)
Product group Antibodies
ReactivityHuman
TargetLAG3
- SizePrice
![Endoglin / CD105 (Angiogenesis Marker)(ENG/3269), CF640R conjugate, 0.1mg/mL [26628-22-8]](https://biotium.com/wp-content/uploads/2019/11/BNUB3269-1.jpg)
Product group Antibodies
ApplicationsImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
ReactivityHuman
TargetENG
- SizePrice
Didn't find what you were looking for?
Search through our product groups to find the right product
Back to overview